Mercator Medsystems, Inc.

ACTIVE

520 McCormick St, 加利福尼亚州阿拉梅达县, California, United Stateswww.mercatormed.comHolding11–50 employeesEstablished: 2000-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2000

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

54.5%

Not Applicable

9.1%

Phase 1

9.1%

Phase 3

9.1%

Phase 4

9.1%

Trial Status Distribution

Active, not recruiting

18.2%

Completed

27.3%

Recruiting

18.2%

Terminated

9.1%

Unknown

27.3%

Clinical Trials

Trials sponsored by this organization (11)

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Phase 3

Recruiting

interventional

Jul 2025250 participants

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Phase 2

Active, not recruiting

interventional

Aug 202260 participants

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

Phase 2

Recruiting

interventional

Oct 202180 participants

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

Phase 2

Terminated

interventional

Oct 201910 participants

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

Phase 2

Unknown

interventional

Mar 2017100 participants

ot applicable

Phase 1

Active, not recruiting

interventional

Sep 2016120 participants

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization

Phase 2

Unknown

interventional

Jun 2016120 participants

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization

Phase 2

Unknown

interventional

Jan 2016120 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations